07/12/2017 12:45:00

Beleave Signs Brand Licensing Agreement with Kevin Smith & Jason Mewes

TORONTO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has entered into a Brand Licensing Agreement with Kevin Smith and Jason Mewes, better known as their onscreen characters, Jay and Silent Bob.  Under the agreement the Company, in partnership with Kevin Smith and Jason Mewes, will be developing various proprietary strains geared towards the recreational market which will be available under the Beleave Kannabis brand.

“We are excited to welcome Kevin and Jason to our team, their passion for the industry is something that resonates with us,” commented Beleave CEO Andrew Wnek. “We look forward to working together to explore unique, outside the box business opportunities over the coming years.”

Kevin Smith is a filmmaker, actor, comic book writer, author, and podcaster well known for his comedy film Clerks (1994), which he wrote, directed, co-produced, and acted in as the character Silent Bob.  Jay and Silent Bob have appeared in Smith's follow-up films Mallrats, Chasing Amy, Dogma, and Jay and Silent Bob Strike Back.

“It’s no secret that I’m a fan of cannabis, it helps me sleep at night and keeps my blood pressure down.  I’ve seen cannabis drastically improve the lives of some of the closest people in my life, and believe it could be a viable alternative to the use of traditional pain killers,” said Kevin Smith.  “This culminating with the changing laws and perception surrounding cannabis has me very excited to team up with Beleave, a group I believe to be one of the most innovative in the Canadian cannabis space.”

“It’s hard for me to argue against the potential benefits that Medical Cannabis can bring.  Much like the Beleave team I have a personal connection to the remedy. Now that Canada is on the verge of legalizing cannabis, I am looking forward to the opportunity to work with the scientifically focused and forward thinking team at Beleave, there’s no telling what we can dream up together,” said Jason Mewes.

Jason Mewes, is perhaps best known as the vocal half of the on-screen comedic duo, Jay and Silent Bob. Mewes’ has reprised his role as celebrated character, “Jay,” in a number of hit films. Mewes has captured audiences with rebellious banter against his unspoken other half and long-time friend, Kevin Smith (Silent Bob).

“Kevin and Jay played the quintessential stoners in a bunch of 90’s comedies, but are serious about the benefits of the cannabis lifestyle,” continued Beleave CEO Andrew Wnek, “It’s definitely going to be fun watching them take an active role in the space while developing strains together.”

About Beleave

Beleave Inc. is a biotech company and Beleave's wholly-owned subsidiary Beleave Kannabis Corp. (formerly First Access Medical Inc.) is a licensed producer pursuant to the ACMPR. Beleave's purpose-built facility is located in Hamilton, Ontario.

For further information please contact:

Sebastian de Kloet

Phone: (905) 979 - 5173 

Email: sebastian@beleave.com

beleave.com

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. These risks and uncertainties include, but are not limited to, the Company's ability to satisfy the conditions associated with its cultivation license, the Company's ability to obtain a sales license and the related timing considerations, the availability of further financing, consumer interest in its products, competition, regulation, operational and technological risks, and anticipated and unanticipated costs and delays. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on

www.sedar.com

.

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
15 Oct
DANSKE
Stop dog for helvede dine sindsyge indlæg. Det er brugere som dig der fuldkommen smadrer det her for..
31
16 Oct
DANSKE
Jeg tror aldrig jeg har oplevet en person, der var så bitter som du er. Du bruger en ufattelig masse..
28
11 Oct
OMXC25
... og det betyder som regel, at det er sidste ben i nedturen, før en pause, eller en positiv modrea..
24
13 Oct
PNDORA
Carnegie's seneste analyse gav lidt medvind til pandora, men det var slet ikke meningen, idet alle j..
21
12 Oct
DANSKE
Ole Andersen havde ansat 5 kanibaler til at ryde op efter hvidvasskandalen. I har nu fast arbejde, t..
21
14 Oct
DANSKE
En korruptionsbekæmper skudt i Moskva, er nu også blevet Danske Banks skyld, hvor ussel kan denne p..
18
12 Oct
DANSKE
Der er noget ejendommeligt ved danmarkshistoriens formentlig største pengeinstitutskandale: Formentl..
15
16 Oct
VELO
HVAD SIGER VELOXIS og HVAD GØR MARKEDET...    Lad os starte med hvad sagde Craig Collard ved regnska..
14
15 Oct
VELO
Hej Veloxis er i dag nævnt som en af de 3 aktier man bør fokusere på. https://play.borsen.dk/klip/5b..
14
13 Oct
CHEMM
@Tommy, Du stiller et meget relevant spørgsmål, men først vil jeg korrigere lidt på dit P/E. Som inv..
14

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union
2
Glance Reports Third Quarter 2018 Results
3
Axiom Real-Time Metrics Exhibiting at OCT Pacific Northwest in Vancouver
4
Ctrip and KLM Sign Strategic Partnership Agreement
5
Atos and Siemens team up to enable enterprises to deploy IoT applications on private Cloud

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 October 2018 00:18:50
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181005.3 - EUROWEB2 - 2018-10-18 01:18:50 - 2018-10-18 00:18:50 - 1000 - Website: OKAY